BMY vs SNY: stock comparison and AI forecast
Bristol Myers Squibb Co (BMY) and Sanofi (SNY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BMY Bristol Myers Squibb Co
- Market Cap
- $129.04B
- P/E Ratio
- 14.0x
- Size
- large-cap
- AI Forecast
SNY Sanofi
- Price
- $46.91 +8.6% · 6M
- Market Cap
- $115.65B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BMY is 1.1 times larger than SNY by market capitalization ($129.04B against $115.65B).
- BMY yields 3.97% in dividends; SNY pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BMY | SNY |
|---|---|---|
| Market Cap | $129.04B | $115.65B |
| P/E Ratio | 13.97x | – |
| P/B Ratio | 5.51x | – |
| Dividend Yield | 3.97% | – |
| EPS | $4.52 | – |
| Book Value/Share | $11.45 | – |
| Revenue/Share | $24.48 | – |
| FCF/Share | $4.54 | – |
Profitability & Margins
| Metric | BMY | SNY |
|---|---|---|
| ROE | 39.5% | 30.0% |
| ROA | 10.4% | 16.9% |
| ROIC | – | 20.7% |
| Gross Margin | 69.2% | – |
| Net Margin | 18.5% | – |
| EBT Margin | 22.6% | – |
| Tax Rate | 18.4% | – |
Financial Health
| Metric | BMY | SNY |
|---|---|---|
| Current Ratio | 1.59x | 1.09x |
| Quick Ratio | 1.44x | 0.73x |
| D/E Ratio | 2.79x | – |
| Financial Leverage | 3.79x | 1.78x |
| Interest Coverage | 42.5x | – |
| Working Capital | $11.01B | $3.06B |
Cash Flow
| Metric | BMY | SNY |
|---|---|---|
| Operating Cash Flow | $10.65B | $28.11B |
| Free Cash Flow | $9.29B | – |
| Capital Spending | -$1.37B | – |
| OCF Growth YoY | -35.9% | -11.9% |
| FCF Growth YoY | -39.3% | – |
| FCF/Sales | 18.6% | – |
| CapEx/Sales | 2.7% | – |
Operational Efficiency
| Metric | BMY | SNY |
|---|---|---|
| Asset Turnover | 0.56x | – |
| Receivables Turnover | 5.4x | – |
| Inventory Turnover | 5.7x | 3.8x |
| Fixed Assets Turnover | 6.3x | – |
| Days Sales Outstanding | 67 days | – |
| Days Inventory | 64 days | 96 days |
| Payables Period | 110 days | – |
| Cash Conversion Cycle | 21 days | – |
Income Statement
| Metric | BMY | SNY |
|---|---|---|
| Total Revenue | $50.03B | – |
| Operating Income | – | $23.11B |
| Net Income | $9.24B | $24.28B |
| R&D Expense | $10.56B | $25.35B |
| SG&A Expense | $7.32B | $32.28B |
| Cost of Goods Sold | $15.39B | $44.17B |
Dividend & Shareholder Information
| Metric | BMY | SNY |
|---|---|---|
| Dividends Per Share | $2.50 | – |
| Payout Ratio | 55.3% | – |
| Shares Outstanding | 2044M | 2465M |
| Net Income Growth | 53.1% | 5.1% |
| EPS Growth | 52.2% | – |
BMY vs SNY: stock comparison and AI forecast
Which is bigger, BMY or SNY?
BMY is 1.1 times larger than SNY by market capitalization ($129.04B against $115.65B).
Which one does Intratio's AI model rank higher, BMY or SNY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.